Craft

ResMed

Stock Price

$244.4

2024-10-29

Market Capitalization

$35.9 B

2024-10-29

Revenue

$5.1 B

FY, 2025

ResMed Summary

Company Summary

Overview
ResMed is a company that develops, manufactures, and distributes medical equipment and software solutions for the healthcare sector. It operates through two segments: Sleep and Breathing Health, and Residential Care Software. The Sleep and Breathing Health segment focuses on products for the treatment and management of sleep and respiratory disorders within the medical device industry. The Residential Care Software segment provides business management software as a service (SaaS) to residential healthcare providers.
Type
Public
Status
Active
Founded
1989
HQ
San Diego, CA, US | view all locations
Website
https://investor.resmed.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Michael Mick Farrell

    Michael Mick Farrell, CEO

    • Rob Douglas

      Rob Douglas, President and Chief Operating Officer

    • David Pendarvis

      David Pendarvis, Chief Administrative Officer, Global General Counsel

    • Jim Hollingshead

      Jim Hollingshead, President, Sleep Business

    Operating MetricsView all

    Patents (US)

    619
    9.6%

    FY, 2023

    Patents Pending

    9.7K
    6.6%

    FY, 2023

    Patents (Foreign)

    1.5K
    2.6%

    FY, 2023

    LocationsView all

    30 locations detected

    • San Diego, CA HQ

      United States

      9001 Spectrum Center Blvd

    • Bella Vista, New South Wales

      Australia

      1 Elizabeth Macarthur Dr

    • Bruxelles, Bruxelles

      Belgium

      Av. du Boulevard 21

    • São Paulo, SP

      Brazil

      Roque Petroni Junior Avenue, 850 Bacaetava Tower

    • Beijing, Bei Jing Shi

      China

      Tai Yang Gong Zhong Lu, Chao Yang Qu

    • Maribo

      Denmark

      Kidnakken 11

    and 24 others

    ResMed Financials

    Summary Financials

    Revenue (Q3, 2026)
    $1.4B
    Gross profit (Q3, 2026)
    $891.0M
    Cash (Q3, 2026)
    $1.7B
    Enterprise value
    $35.1B

    Footer menu